Enfusion, Inc. (ENFN)
NYSE: ENFN · IEX Real-Time Price · USD
10.45
-0.49 (-4.48%)
Mar 17, 2023, 4:00 PM EDT - Market closed
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|
| Revenue | 150.35 | 111.7 | 79.57 | 59.03 |
| Revenue Growth (YoY) | 34.60% | 40.39% | 34.79% | - |
| Cost of Revenue | 47.1 | 31.85 | 21.36 | 16.96 |
| Gross Profit | 103.25 | 79.86 | 58.21 | 42.07 |
| Selling, General & Admin | 98.05 | 202.34 | 45.82 | 24.05 |
| Research & Development | 17.16 | 153.4 | 6.32 | 4.15 |
| Operating Expenses | 115.21 | 355.74 | 52.13 | 28.2 |
| Operating Income | -11.96 | -275.88 | 6.07 | 13.87 |
| Interest Expense / Income | -0.41 | 4.59 | 1.66 | 0.72 |
| Other Expense / Income | -4.97 | -122.74 | -0.08 | 0 |
| Pretax Income | -6.58 | -157.74 | 4.49 | 13.14 |
| Income Tax | 1.07 | 0.58 | 0.43 | 0.49 |
| Net Income | -7.65 | -158.32 | 4.06 | 12.66 |
| Net Income Growth | - | - | -67.91% | - |
| Shares Outstanding (Basic) | 85 | 83 | 113 | - |
| Shares Outstanding (Diluted) | 85 | 83 | - | - |
| Shares Change | 2.83% | -26.54% | - | - |
| EPS (Basic) | -0.10 | -2.26 | - | - |
| EPS (Diluted) | -0.10 | -2.26 | - | - |
| Free Cash Flow Per Share | 0.07 | -0.10 | -0.03 | - |
| Gross Margin | 68.67% | 71.49% | 73.16% | 71.27% |
| Operating Margin | -7.96% | -246.99% | 7.63% | 23.50% |
| Profit Margin | -5.09% | -141.73% | 5.10% | 21.44% |
| Free Cash Flow Margin | 4.14% | -7.46% | -4.28% | 13.34% |
| Effective Tax Rate | - | - | 9.64% | 3.70% |
| EBITDA | -0.39 | -149.17 | 8.45 | 15.02 |
| EBITDA Margin | -0.26% | -133.54% | 10.62% | 25.45% |
| Depreciation & Amortization | 6.6 | 3.98 | 2.29 | 1.16 |
| EBIT | -6.99 | -153.14 | 6.16 | 13.87 |
| EBIT Margin | -4.65% | -137.10% | 7.74% | 23.49% |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).